129 related articles for article (PubMed ID: 9365453)
61. Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcoma.
Raimundo K; Biskupiak J; Goodman M; Silverstein S; Asche C
J Med Econ; 2013; 16(5):606-13. PubMed ID: 23425295
[TBL] [Abstract][Full Text] [Related]
62. Pharmacoeconomics of liposomal anthracycline therapy.
Bennett CL; Calhoun EA
Semin Oncol; 2004 Dec; 31(6 Suppl 13):191-5. PubMed ID: 15717744
[TBL] [Abstract][Full Text] [Related]
63. [Classical Kaposi's sarcoma in a 78-year-old woman].
Antal AS; Homey B; Reifenberger J; Hengge UR
Hautarzt; 2008 Apr; 59(4):276-8. PubMed ID: 18338143
[No Abstract] [Full Text] [Related]
64. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
[TBL] [Abstract][Full Text] [Related]
65. Hepatic toxicity of liposomal encapsulated doxorubicin.
Coker RJ; James ND; Stewart JS
Lancet; 1993 Mar; 341(8847):756. PubMed ID: 8095649
[No Abstract] [Full Text] [Related]
66. Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma.
Uthayakumar S; Bower M; Money-Kyrle J; Muyshondt C; Youle M; Hannon F; Phillips R; Gazzard BG; Boag F
AIDS; 1996 May; 10(5):515-9. PubMed ID: 8724043
[TBL] [Abstract][Full Text] [Related]
67. Misprint of dosage interval for liposomal doxorubicin hydrochloride.
Subach RA; Ruble J
Am J Health Syst Pharm; 1996 Jul; 53(14):1727. PubMed ID: 8827244
[No Abstract] [Full Text] [Related]
68. Doxil offers hope to KS sufferers.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097
[TBL] [Abstract][Full Text] [Related]
69. Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Chemotherapy of AIDS-Related Kaposi's Sarcoma: A Meta-Analysis.
Liu R; Zhou J; Yang S; Zhang Z
Am J Ther; 2018; 25(6):e719-e721. PubMed ID: 29509553
[No Abstract] [Full Text] [Related]
70. Development of liposomal anthracyclines: from basics to clinical applications.
Gabizon A; Goren D; Cohen R; Barenholz Y
J Control Release; 1998 Apr; 53(1-3):275-9. PubMed ID: 9741935
[TBL] [Abstract][Full Text] [Related]
71. Classic Kaposi's sarcoma presenting first with gastrointestinal tract involvement in a HIV-negative Inuit male--a case report and review of the literature.
Balachandra B; Tunitsky E; Dawood S; Hings I; Marcus VA
Pathol Res Pract; 2006; 202(8):623-6. PubMed ID: 16682127
[TBL] [Abstract][Full Text] [Related]
72. Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection.
Fournier S; Dupont B; Pialoux G; Eliaszewicz M; Gonzalez-Canali G; Feuillie V
Arch Dermatol; 1997 Jul; 133(7):918-9. PubMed ID: 9236538
[No Abstract] [Full Text] [Related]
73. Kaposi's sarcoma of the tonsils.
Wright B
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28790048
[No Abstract] [Full Text] [Related]
74. Fatal hepatic failure with liposomal doxorubicin.
Hengge UR; Brockmeyer NH; Rasshofer R; Goos M
Lancet; 1993 Feb; 341(8841):383-4. PubMed ID: 8094161
[No Abstract] [Full Text] [Related]
75. Retinoids promising in Kaposi's sarcoma trials.
Ault A
Lancet; 1998 Apr; 351(9110):1185. PubMed ID: 9643704
[No Abstract] [Full Text] [Related]
76. Conjunctival involvement in classic (indolent) HIV negative Kaposi's sarcoma.
Ron IG; Kremer I; Lowenstein A; Chaitchik S
Br J Ophthalmol; 1994 Jun; 78(6):488-9. PubMed ID: 8060937
[No Abstract] [Full Text] [Related]
77. [Liposomal adriamycin: preparation, administration, and toxicity monitoring. Nursing aspects].
Panzolini S
Suppl Tumori; 2004; 3(4):S120. PubMed ID: 15206235
[No Abstract] [Full Text] [Related]
78. Intralesional mitomycin-C for the treatment of conjunctival Kaposi sarcoma.
Korn BS; Park DJ; Kikkawa DO
Ophthalmic Plast Reconstr Surg; 2011; 27(4):e88-90. PubMed ID: 21178794
[TBL] [Abstract][Full Text] [Related]
79. Orificial tuberculosis and Kaposi's sarcoma in an HIV-negative individual.
Chen YJ; Shieh PP; Shen JL
Clin Exp Dermatol; 2000 Jul; 25(5):393-7. PubMed ID: 11012593
[TBL] [Abstract][Full Text] [Related]
80. Changes in Kaposi's sarcoma induced by dapsone.
Fanti PA; Tosti A; Pileri S
Clin Exp Dermatol; 1991 Nov; 16(6):441-3. PubMed ID: 1806319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
